BackBackNet income of NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL
Annual data
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
−450.00 M
0.00
450.00 M
900.00 M
1.35 B
Period
Value
Change
Change %
TTM
−422.97 M
−233.52 M
−123.27%
2023
−189.45 M
−1.28 B
−117.37%
2022
1.09 B
+31.54 M
+2.98%
2021
1.06 B
+253.17 M
+31.41%
2020
806.12 M
+201.16 M
+33.25%
2019
604.96 M
+180.41 M
+42.50%
Quarterly data
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−1.05 B
−700.00 M
−350.00 M
0.00
350.00 M
Period
Value
Change
Change %
Q3 '24
200.77 M
−27.06 M
−11.88%
Q2 '24
227.83 M
+50.64 M
+28.58%
Q1 '24
177.19 M
+1.21 B
—
Q4 '23
−1.03 B
−1.24 B
−578.92%
Q3 '23
214.81 M
−77.37 M
−26.48%
Q2 '23
292.18 M
−40.15 M
−12.08%
Q1 '23
332.33 M
+148.54 M
+80.82%
Q4 '22
183.79 M
−109.22 M
−37.28%